Attention Deficit: Labs to Order and Next Steps

Why Attention Deficit Requires a Lab Workup

Attention deficit is a symptom, not a diagnosis. Before attributing persistent inattention to ADHD, clinicians need to exclude medical conditions that present with identical cognitive complaints. The 2023 American Academy of Pediatrics (AAP) clinical practice guideline emphasizes that "medical conditions such as thyroid disease, anemia, and sleep disorders should be evaluated before confirming an ADHD diagnosis" [1]. This principle applies equally to adults.

A focused laboratory panel costs less than a single neuropsychological testing session and can identify treatable conditions within days. Hypothyroidism alone affects approximately 4.6% of the U.S. population aged 12 and older according to NHANES data published by the National Institute of Diabetes and Digestive and Kidney Diseases [2]. Subclinical thyroid dysfunction can produce concentration difficulties, mental fog, and task-switching problems that overlap entirely with ADHD presentations.

Iron deficiency without frank anemia is another overlooked contributor. A 2004 study by Konofal et al. (N=53 children with ADHD, 27 controls) found that 84% of the ADHD group had serum ferritin levels below 30 ng/mL, compared with 18% of controls (P<0.001) [3]. The takeaway is straightforward: skipping labs means potentially missing a correctable cause. Every patient presenting with new or worsening attention complaints deserves at minimum a targeted blood panel before proceeding to psychometric evaluation.

The Core Lab Panel for Attention Deficit

The standard workup for attention deficit symptoms includes five categories of tests. Each targets a specific physiological system known to affect cognitive function. Order these before referring for formal ADHD assessment.

Thyroid function (TSH, free T4). Both overt and subclinical hypothyroidism impair working memory and processing speed. A 2015 meta-analysis in the Journal of Clinical Endocrinology and Metabolism (12 studies, N=23,944) found subclinical hypothyroidism was associated with reduced cognitive function across multiple domains, including attention [4]. TSH above 4.5 mIU/L with low-normal free T4 warrants endocrine follow-up.

Iron studies (serum ferritin, TIBC, serum iron). Ferritin is the most clinically relevant marker. Brain iron is required for dopamine receptor density and dopamine transporter function in the basal ganglia. A 2012 meta-analysis by Defined and colleagues published in BMC Psychiatry found significantly lower mean ferritin in children with ADHD compared to controls (weighted mean difference: −8.55 ng/mL, 95% CI: −14.10 to −3.00) [5]. Target ferritin above 30 ng/mL; some clinicians aim for above 50 ng/mL before ruling out iron-related cognitive effects.

Complete blood count (CBC). Screens for anemia, infection, and hematologic abnormalities. Chronic anemia from any cause reduces oxygen delivery to prefrontal regions responsible for executive function.

Comprehensive metabolic panel (CMP). Evaluates renal and hepatic function, electrolytes, and glucose. Hypoglycemic episodes and hepatic encephalopathy can both mimic ADHD symptom clusters [6].

25-hydroxyvitamin D. A 2018 meta-analysis in the Journal of Child Psychology and Psychiatry (N=10,334 across 25 studies) reported that children with ADHD had significantly lower vitamin D levels than controls (standardized mean difference: −0.57, 95% CI: −0.82 to −0.31) [7]. While causation is not established, repletion of deficient levels (below 20 ng/mL) is standard care regardless of the ADHD question.

Optional and Second-Line Investigations

Not every patient needs an expanded panel. Reserve these tests for cases where the clinical picture suggests a specific differential or where first-line labs return equivocal results.

Lead level. Blood lead screening is appropriate for patients with environmental exposure history. Even low-level lead exposure (blood lead 1.0 to 2.0 µg/dL) was associated with a 2.3-fold increased risk of meeting ADHD criteria in NHANES III data (N=4,704 children aged 4 to 15) [8]. This risk is dose-dependent.

Sleep study (polysomnography). Obstructive sleep apnea (OSA) produces daytime inattention indistinguishable from ADHD. The American Academy of Sleep Medicine estimates OSA affects 2 to 4% of children and up to 26% of adults aged 30 to 70 [9]. Screen with the STOP-Bang questionnaire first. A score of 3 or higher warrants formal polysomnography.

Cortisol and DHEA-S. Cushing syndrome and adrenal insufficiency can produce concentration difficulties. These tests are warranted only with suggestive clinical findings: unexplained weight gain, striae, proximal weakness, or chronic fatigue out of proportion to sleep quality.

Omega-3 fatty acid index (RBC membrane EPA+DHA). A 2017 meta-analysis published in Neuropsychopharmacology (16 RCTs, N=1,408) found that omega-3 supplementation produced a small but significant improvement in inattention symptoms (effect size: 0.28, P=0.001) [10]. Checking the omega-3 index may guide supplementation decisions.

Genetic testing. Pharmacogenomic panels (CYP2D6, CYP1A2, COMT polymorphisms) can inform stimulant and non-stimulant medication selection but do not establish or rule out ADHD itself. These are most useful after a confirmed diagnosis, when choosing between methylphenidate and amphetamine classes.

Medical Conditions That Mimic Attention Deficit

Ruling out mimics is the entire purpose of the pre-assessment lab workup. The differential for adult attention deficit is broad. This framework organizes the most common mimics by organ system.

Endocrine. Hypothyroidism (overt or subclinical), hyperthyroidism (causes restlessness misread as hyperactivity), type 2 diabetes with glycemic variability, and Cushing syndrome. Thyroid disorders alone account for a meaningful fraction of attention complaints in primary care settings.

Hematologic. Iron deficiency anemia, B12 deficiency (serum methylmalonic acid is more sensitive than B12 alone), and folate deficiency. All reduce oxygen delivery or impair methylation pathways critical to neurotransmitter synthesis.

Psychiatric. Major depressive disorder, generalized anxiety disorder, bipolar II (depressive phase), PTSD, and substance use disorders. Dr. Stephen Faraone, Distinguished Professor of Psychiatry at SUNY Upstate Medical University, has noted that "the overlap between ADHD and mood disorders is substantial, and accurate differential diagnosis requires longitudinal history, not a cross-sectional snapshot" [11].

Neurologic. Traumatic brain injury (even mild), early-stage neurodegenerative conditions, and chronic migraine with interictal cognitive fog. Sleep disorders span both neurologic and pulmonary categories: narcolepsy type 2, circadian rhythm disorders, and restless legs syndrome all fragment sleep architecture and produce daytime inattention.

Pharmacologic. Antihistamines, benzodiazepines, opioids, antiepileptics (especially topiramate), and beta-blockers can impair concentration. A careful medication reconciliation is zero-cost and takes minutes.

How ADHD Is Formally Diagnosed

Once labs exclude medical mimics, formal ADHD assessment follows a structured process. There is no blood test for ADHD itself. Diagnosis remains clinical, based on DSM-5-TR criteria.

The DSM-5-TR requires six or more symptoms of inattention (for those under 17) or five or more (age 17 and older) persisting for at least six months, with onset before age 12, present in two or more settings, and causing functional impairment [12]. Symptom counts alone are not sufficient. The criteria demand clear evidence that symptoms interfere with social, academic, or occupational functioning.

Validated screening instruments. The Adult ADHD Self-Report Scale version 1.1 (ASRS-v1.1), developed in collaboration with the World Health Organization, has a sensitivity of 91.4% and specificity of 96.0% for adult ADHD in the primary care validation study (N=154) [13]. It takes under five minutes. The Conners Adult ADHD Rating Scale (CAARS) and the Wender Utah Rating Scale provide additional data points.

Structured clinical interview. The Diagnostic Interview for ADHD in Adults (DIVA 5.0) walks through each DSM-5 symptom domain with concrete behavioral examples from childhood and adulthood. This interview typically requires 60 to 90 minutes and remains the gold standard.

Collateral information. Report cards, prior evaluations, and informant ratings from a spouse, parent, or close colleague strengthen diagnostic confidence. The APA Practice Guidelines recommend obtaining at least one collateral source whenever possible [14].

Neuropsychological testing. Not required for diagnosis in straightforward cases. Reserve comprehensive testing (CPT-3, TOVA, full battery) for patients with comorbid learning disabilities, head injury history, or diagnostic ambiguity.

Treatment Pathways After Diagnosis

Treatment for ADHD follows a multimodal model. The evidence base supports pharmacotherapy as first-line for moderate to severe ADHD in adults, with behavioral interventions as adjuncts.

Stimulant medications. Methylphenidate (Concerta, Ritalin) and amphetamine salts (Adderall, Vyvanse) are first-line. A 2018 Lancet Psychiatry network meta-analysis (133 RCTs, N=22,356) by Cortese et al. found amphetamines were the most efficacious pharmacotherapy for adult ADHD (standardized mean difference vs. placebo: −0.79, 95% CI: −0.99 to −0.58), while methylphenidate was the best first choice for children [15]. Approximately 70% of adults respond to the first stimulant tried; switching classes captures an additional 10 to 15%.

Non-stimulant options. Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor with a slower onset (4 to 6 weeks to full effect). Viloxazine extended-release (Qelbree), FDA-approved in 2021 for adults, offers another non-stimulant pathway. Guanfacine extended-release and clonidine extended-release are approved for pediatric use and used off-label in adults, primarily for hyperactivity and impulsivity rather than inattention.

Behavioral interventions. Cognitive behavioral therapy (CBT) adapted for ADHD targets executive function deficits: planning, time management, organizational skills, and emotional regulation. A 2018 RCT by Safren et al. (N=86) published in JAMA Psychiatry demonstrated that CBT plus medication produced significantly greater improvement than medication alone (effect size: 0.44 for ADHD symptoms, P=0.01) [16].

Lifestyle modifications with evidence. Regular aerobic exercise (150 minutes per week) improves executive function in adults with ADHD. A 2019 meta-analysis in the Journal of Attention Disorders (15 studies) found moderate effect sizes for exercise on attention (Hedges' g = 0.47) [17]. Sleep hygiene is non-negotiable: adults with ADHD have a 73% prevalence of sleep-onset insomnia. Protein-containing breakfasts stabilize morning blood glucose and may reduce medication-related appetite suppression later in the day.

When to Seek Specialist Referral

Not every attention complaint requires a specialist. But certain scenarios warrant referral to psychiatry, neurology, or endocrinology. Act on these triggers.

Refer to psychiatry or neuropsychology when: screening scores are elevated but the clinical picture is ambiguous, there is significant psychiatric comorbidity (bipolar disorder, PTSD, substance use), the patient has failed two medication trials, or the patient is older than 50 with new-onset attention symptoms (late-onset ADHD is rare and warrants careful differential workup).

Refer to endocrinology when: TSH is abnormal or borderline, there are signs of cortisol excess, or thyroid antibody titers suggest Hashimoto thyroiditis as a cause of fluctuating cognitive symptoms.

Refer to a sleep medicine specialist when: the STOP-Bang score is 3 or higher, the patient reports excessive daytime sleepiness, or there is a history of witnessed apneas. Treating OSA alone resolves attention complaints in a subset of patients who would otherwise receive an ADHD diagnosis.

Refer to neurology when: there is a history of head injury with loss of consciousness, progressive cognitive decline, focal neurologic signs, or seizure-like episodes. Absence seizures in adults are rare but present with brief attentional lapses that can be mistaken for ADHD.

The clinician's job is pattern recognition. A 35-year-old with lifelong inattention, childhood report cards noting "does not stay on task," and a first-degree relative with ADHD has a very different pretest probability than a 52-year-old with new-onset concentration problems and a 15-pound weight gain over six months. Labs distinguish these paths.